RenaissanceRe (NYSE:RNR) Given New $306.00 Price Target at Wells Fargo & Company

RenaissanceRe (NYSE:RNR) had its target price lifted by analysts at Wells Fargo & Company from $281.00 to $306.00 in a note issued to investors on Thursday,Benzinga reports. The firm presently has an “equal weight” rating on the insurance provider’s stock. Wells Fargo & Company‘s price target indicates a potential downside of 0.92% from the company’s previous close.

Other equities research analysts have also recently issued reports about the stock. Cantor Fitzgerald upped their price objective on shares of RenaissanceRe from $252.00 to $282.00 and gave the stock a “neutral” rating in a report on Wednesday, January 14th. Barclays boosted their price target on shares of RenaissanceRe from $278.00 to $304.00 and gave the company an “equal weight” rating in a research report on Thursday, January 8th. UBS Group boosted their target price on RenaissanceRe from $265.00 to $272.00 and gave the stock a “neutral” rating in a research report on Wednesday, October 8th. Weiss Ratings reissued a “buy (b)” rating on shares of RenaissanceRe in a report on Monday, December 29th. Finally, TD Cowen restated a “hold” rating on shares of RenaissanceRe in a report on Thursday, January 8th. Five research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $300.27.

RenaissanceRe Stock Up 2.8%

Shares of RNR traded up $8.47 during mid-day trading on Thursday, reaching $308.84. The company’s stock had a trading volume of 375,195 shares, compared to its average volume of 379,995. The company has a market cap of $14.24 billion, a price-to-earnings ratio of 5.45, a price-to-earnings-growth ratio of 2.99 and a beta of 0.24. The business has a fifty day moving average of $274.43 and a 200 day moving average of $258.26. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 0.21. RenaissanceRe has a 1 year low of $219.00 and a 1 year high of $310.80.

RenaissanceRe (NYSE:RNR) last posted its quarterly earnings results on Tuesday, February 3rd. The insurance provider reported $13.34 earnings per share for the quarter, beating the consensus estimate of $10.59 by $2.75. The firm had revenue of $2.97 billion for the quarter, compared to analyst estimates of $1.73 billion. RenaissanceRe had a return on equity of 18.61% and a net margin of 20.88%.RenaissanceRe’s quarterly revenue was up 29.6% on a year-over-year basis. During the same period in the previous year, the firm earned $8.06 earnings per share. As a group, analysts forecast that RenaissanceRe will post 26.04 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of RNR. Northwestern Mutual Wealth Management Co. raised its position in RenaissanceRe by 19,961.9% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 98,905 shares of the insurance provider’s stock valued at $27,808,000 after buying an additional 98,412 shares during the last quarter. Arbejdsmarkedets Tillaegspension bought a new position in shares of RenaissanceRe in the 4th quarter valued at about $24,826,000. Allworth Financial LP lifted its stake in RenaissanceRe by 78.8% in the 4th quarter. Allworth Financial LP now owns 363 shares of the insurance provider’s stock valued at $102,000 after purchasing an additional 160 shares during the last quarter. Independent Advisor Alliance increased its position in RenaissanceRe by 9.8% during the fourth quarter. Independent Advisor Alliance now owns 931 shares of the insurance provider’s stock worth $262,000 after buying an additional 83 shares during the last quarter. Finally, World Investment Advisors bought a new stake in RenaissanceRe in the fourth quarter valued at approximately $210,000. 99.97% of the stock is owned by institutional investors and hedge funds.

RenaissanceRe News Summary

Here are the key news stories impacting RenaissanceRe this week:

• Positive Sentiment: Q4 results materially beat expectations — EPS $13.34 vs. consensus $10.59 and revenue $2.97B (≈+29.6% YoY), signaling stronger profitability and margin expansion. RenaissanceRe Q4 press release / MarketBeat
• Positive Sentiment: Lower claims costs and strong investment performance boosted underwriting income and overall results, a central point in analyst write-ups that helps justify the rally. Zacks: Q4 beat on lower claims costs
• Positive Sentiment: Company commentary (earnings call transcript) reinforced the beats and provided management color on reserves, reinsurance pricing trends and capital deployment — supporting investor confidence. Earnings call transcript
• Neutral Sentiment: Analyst reaction is mixed: Evercore ISI raised its price target from $283 to $291 but kept an “in-line” rating, implying limited upside from that shop despite the beat. Evercore price target note (Benzinga/TickerReport)
• Neutral Sentiment: Some coverage frames RNR as undervalued on quality metrics and low multiples (P/E ~5.4), which may attract value investors but doesn’t guarantee near-term momentum. MSN: valuation piece
• Negative Sentiment: Premium growth remains mixed — some articles note weaker premiums in the quarter even as underwriting income rose, a potential red flag if pricing momentum stalls. Zacks: weaker premiums noted

About RenaissanceRe

RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance solutions, specializing in property catastrophe, casualty, and specialty lines. Established in 1993 and headquartered in Bermuda, the company trades on the New York Stock Exchange under the symbol RNR. With a focus on underwriting and risk assessment, RenaissanceRe offers tailored programs designed to help insurers and corporations manage exposure to natural disasters, liability claims, and other complex risks.

The company operates through two primary segments: Reinsurance and Insurance.